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wherever applicable. Our study tried to point out its implication in
intermediate stenosis and how it is more decisive than software
derived measurement (QCA) in a real world scenario.
Procedure: Total 27 patients (age 62.77  11.39 years) who received
FFR for intermediate stenosis, were included in this study. All
patients had evidence of ischemia either as stable angina
(56.26%), unstable angina (33.33%) or postMI angina (7.41%). Hyper-
tension (74.07%) and diabetes mellitus (29.63%) are most prevalent
risk factors present within patient group. In 85.19% cases, patients
have multi-vessel disease. Total patient group is subdivided into
left alone (70.37%) and stented (29.63%) as per FFR cut off value (0.8)
and both were kept under stringent medical management with
optimal antiplatelet and statin therapy. Mean follow-up period
was 18 months and primary outcome was recorded in reference to
TLR (target lesion re-stenosis) or MACE (major adverse cardiac
event).
Result: In 18months follow-up, patients of both subgroup emerged
quite well in outcome of the procedure as only 2 TLR (7.4%) have
identiﬁed one from each sub-group. In both the cases, HTN andDM
are concomitantly present as risk factors.
We observed that there is statistically highly signiﬁcant difference
in FFR score between two sub groups (0.88 vs. 0.75, p < 0.001), while
this is non-signiﬁcant in QCA score (0.66 vs. 0.71, p = 0.08) in
respective sub groups.
Both left alone sub-group and stented sub-group showed good
outcome (94.74% and 87.7%) in respect to disease free life and
Kaplan–Meier analysis for survival also corroborated the same
as it predicted excellent survival in both left alone sub groups
(0.9444; CI: 0.706–0.994) and stented sub-group (0.888; CI: 0.506–
0.994).
Inference: FFR is effective tool in deciding hemodynamically non-
signiﬁcant epicardial coronary artery stenosis with similar out-
come as compared to global PCI outcome. Moreover, this is proved
to be much superior to QCA score in judging effectiveness of
the management strategies and avoiding unnecessary coronary
stenting.
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Background: Trans-catheter closure of perimembranous defects
with the asymmetric device has been controversial due to a high
incidence of atrioventricular conduction disturbances. The use of
Amplatz duct occluders in carefully selected patients may reduce
this complication.
Aim: To evaluate the immediate and mid-term incidence of AV
conduction disturbances following transcatheter device closure of
perimembranous ventricular septal defect device (PMVSD) using
Amplatzer Duct Occluders.
Methods: Twenty-one patients with perimembranous VSD with
signiﬁcant left-to-right shunt (assessed by left ventricular dimen-
sion Z scores) were selected for trans-catheter closure. Patients
with weight <10 kg or with defects within 4 mm distance from the
aortic valve, or with large defects (size greater than the aortic
annulus) were excluded. The size of the device was chosen based
on the trans-esophageal dimension of the defect at the LV end
(2 mm larger device size for ADO 1 and 1 mm larger for ADO II).
Sixteen patients were available for follow-up, of which 13 had their
defects closed with the ADO I device and three with the ADO II
device. Patients were followed up clinically and with electrocar-
diography and trans-thoracic echocardiography at 1, 6, and
12 months. Holter monitoring was performed in all patients at
six months.
Results: Themean age of the patients was 10.2  9.2 years, and the
mean weight was 23.6  15.06 kg. The mean defect size (at the LV
end) was 4.02  0.98 mm. The mean follow-up period was 12.09
 1.92 months. The procedure was successful in all 21 patients,
with complete closure of the defect by 24 h as assessed on TTE. No
patient developed signiﬁcant aortic regurgitation. One patient had
device (ADO II) embolization to the left pulmonary artery within
24 h. The device was retrieved percutaneously and the defect was
closed successfully with ADO I device of a larger size. One patient
developed transient RBBB on table, which reverted spontaneously
allowing successful completion of the procedurewith noAV blocks
thereafter. No patients developed AV blocks in the peri-procedural
period. In 16 patients who were followed up, all were asympto-
matic on follow-up. None developed AV conduction disturbances
on ECG or Holter examination.
Conclusion: In carefully selected patients with small to moderate
perimembranous VSDs, transcatheter closure using the ADO I and
ADO II device can be considered to be a safe and effective alter-
native to surgery, with no AV conduction blocks observed at mid-
term follow-up. Longer follow-up with a larger study population is
desirable.
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Background: Signiﬁcant unprotected left main coronary artery
disease occurs in 5–7% of patients undergoing coronary angiogra-
phy (CAG). This study has focused on safety and efﬁcacy of LMCA
stenting to determine whether it provides a true alternative to
CABG.
Materials and methods: From July 2013 to February 2015, 50
patients underwent LMCA stenting. LMCA stenting was performed
in patients with following criteria (1) Patients with LMCA stenosis
more than 50% and evidence of myocardial ischemia and who
denied CABG as revascularization procedure. (2) Patients with
signiﬁcant ostioproximal lesion of LAD or LCX, who are planned
to be treated with LMCA to LAD or LMCA to LCX stenting. (3)
Patients with bail out LMCA stenting. (4) Stenting of unprotected
LMCA stenosis in selected patients.
Results: Mean age was 53.14  9.60 years. 18 patients who under-
went LMCA stenting presentedwith STEMI, 9 (18%) had NSTEMI, 10
(20%) had unstable angina and 13 (26%) had chronic stable angina.
6 patients had protected LMCAand the rest had unprotected LMCA.
On CAG, 16 (32%) patients had ostial LMCA lesion, 12 (24%) hadmid
LMCA lesion, distal LMCA was diseased in 6 (12%). In emergency
situation, 2 bail out LMCA stenting were done for treatment of
LMCA dissection. 22 (44%) patients had LMCA stenosis less than
50%, 6 (12%) had stenosis between 50 and 70%, 19 (38%) had 71–90%
stenosis and 3 had more than 90%. 42 (84%) patients had low
syntax score, 6 (12%) had intermediate and 2 (4%) had high syntax
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score. Only LMCA stenting was done in 22 (44%) patients, LMCA TO
LAD stenting was done in 22 and LMCA TO LCX stenting was done
in 6 (12%) patients. DESwere used in 35 (70%) cases while BMSwere
used in 15 (30%). Mean stent diameter and length were 3.53
 0.41 mm and 19.27  7.89 mm, respectively. Out of 20% patients
who underwent check CAG, 8% had signiﬁcant ISR for which they
underwent TLR. 8% mortality was observed.
Conclusion: LMCA angioplasty with stent implantation is a safe
procedure in selected patients.
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Aims: The exact cause and management of no ﬂow/slow ﬂow
remains elusive till date and the incidence of no ﬂow increases
as the duration of door to balloon time increases in primary
angioplasty. One of the main reasons for this complication is clot
embolization to distal vessels due to too much manipulation of an
organized clot by catheter and balloons. If after one or two
attempts of thrombosuction the ﬂow in the culprit vessel does
not improve, thenwe try to place the aspiration catheter as distally
as possible and infuse 1–2 mg of nicorandil solution diluted with
50% of contrast solution. This modiﬁcation has two advantages,
the distal vessel is well delineated, the extent of the lesion can be
assessed well and the whole clot can be entrapped by appropriate
sized stent establishing Thrombolysis in myocardial infarction
(TIMI) III ﬂow. Secondly locally delivered high concentration of
nicorandil in the infarct vessel reduces coronary spasm and pro-
tects from ischemic reperfusion injury when the vessel opens up.
Methods and results: Between March 2013 and March 2015, 30
STEMI patients with thrombotic total occlusion of arteries during
primary angioplasty were retrospectively analyzed. The results of
using this novelmethod of infusing intracoronary nicorandil in the
distal culprit vessel through a coronary thrombus aspiration cathe-
ter (number of patients 16) were compared to those patients with-
out the use of this method (number of patients 14). Mean age of
presentation was 57  8 years, more than half of the patients were
males (60%) and the majority was anterior wall myocardial infarc-
tion (50%). The culprit vessel was left anterior descending artery
LAD in the majority of cases (50%) right coronary artery RCA (30%)
and the rest (20%) were left circumﬂex artery. The average window
period of presentation was 10  2 h. 14 patients were in cardio-
genic shock and intra aortic balloon pump (IABP) was used in all
these patients. In allMI patients, thrombus aspiration catheterwas
used, and Gp2b3a inhibitors were used in 10 cases. In 12 out of 16
patients, TIMI III ﬂow and goodmyocardial blush were achieved by
using this innovative approach. Repeated thrombosuction by
aspiration catheters or predilatation of the thrombotic lesions
yielded adequate ﬂow and good myocardial blush in only 5 out
of 14 cases ( p = 0.03). In the ﬁrst group, where intracoronary nicor-
andil was given, 2 out of 16 patients succumbed, while in other
group 4 out of 14 patients died at the end of 30 days ( p = 0.27).
Conclusions: Our initial analysis revealed that use of this novel
concept of infusing intracoronary nicorandil mixed with contrast
beyond the totally occluded culprit vessels in acute MI patients
helps to achieve better myocardial perfusion during primary
angioplasty with improved survival outcomes. However, larger
scale prospective multifactorial adjusted, randomized controlled
studies are required to conﬁrm our preliminary ﬁndings.
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Introduction: Angioplasty and stenting (PCI) gives good results for
diseased Saphenous Vein Grafts (SVG) but is disappointing in
occluded grafts, primarily owing to ‘‘clot clogging of the tribu-
tary-lacking conduits’’. In fact, PCI is considered a contraindication
in totally occluded SVGs. However, recently occluded grafts could
have a better chance of good result with PCI; we report a small
series of such cases.
Case report: Four patients, all male, who underwent CABG surgery
more than a decade ago (10.5–19.5 years) presenting with Non-ST
elevation Myocardial Infarction (NSTEMI). Two patients under-
went CAG elsewhere and were referred here for SVG angioplasty
for critical 90% stenosis in the proximal graft to OM and RCA,
respectively. Two others underwent CAG in our center and had
critical proximal graft stenosis (one SVG to OM and the other was
radial artery graft to OM).
All underwent transfemoral procedure. Initial angiography shots
revealedproximally occludedgrafts. The time interval betweenCAG
and admission for PCI was 3–14 days. In view of continuing anginal
symptoms, absence of other disease to account for the symptoms,
awareness of prior anatomy of SVG and disease, and quite short
historyafterpossible total occlusion, itwasdecided togoaheadwith
PCI of the occluded grafts. Minimally invasive ‘‘primary PCI-like’’
technique was used in all and was successful and uncomplicated.
Drug Eluting Stents were used. Slow-ﬂow and no-ﬂow were not
encountered in any. Post PCI, patients had good symptomatic relief.
Conclusion: Even though PCI is considered a contraindication for
totally occluded SVGs, there is a subset of recently occluded grafts,
which respond to PCI with good outcomes. Use of ‘‘primary PCI-
like’’ techniques helps in preventing or minimizing slow-ﬂow and
no-ﬂow.
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Aims: Transradial approach is more than a default technique and
access of choice for coronary procedures because of patient com-
fort and less access site bleeding. Left radial approach is better than
right radial approach in terms of catheter manipulation and more
patient comfort. Operator's ‘‘learning curve’’ is a factor to achieve
this technical superiority. Guide catheter size and type play an
important role in achieving the procedural success in radial
approach. The aim of this study is to compare 5 F vs. 6 F guide
catheter in left radial approach for coronary intervention (PCI) in
diabetic population performed by a single operator to avoid opera-
tor bias.
Methods and results: This is a single center and exclusively single
operator randomized study including diabetic patients more than
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